GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly(ADP-ribose) polymerase
- PMID: 11095954
- DOI: 10.1006/bbrc.2000.3816
GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly(ADP-ribose) polymerase
Abstract
GPI 6150 (1,11b-dihydro-[2H]benzopyrano[4,3,2-de]isoquinolin-3-one) is a novel inhibitor of poly(ADP-ribose) polymerase (PARP). It has demonstrated efficacy in rodent models of focal cerebral ischemia, traumatic brain injury, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine damage to dopaminergic neurons, regional myocardial ischemia, streptozotocin-induced diabetes, septic shock, and arthritis. Here we report the structure of GPI 6150, its enzymatic characteristics, and biochemical property in cytoprotection. As a competitive PARP inhibitor (K(i) = 60 nM), GPI 6150 protected the P388D1 cells against hydrogen peroxide cytotoxicity, by preventing PARP activation and the depletion of NAD(+), the substrate for PARP. To address the concerns of potential side effects of PARP inhibition, we tested GPI 6150 and found it had no effect on the repair and expression of a plasmid DNA damaged by N-methyl-N'-nitro-N-nitrosoguanidine. Neither did it affect dehydrogenases with NAD co-enzyme. GPI 6150 was much less potent to inhibit mono-ADP-ribosyltransferase. There was no selectivity for GPI 6150 between PARP isozymes. These attributes render GPI 6150 a useful tool to probe the functions of PARP.
Copyright 2000 Academic Press.
Similar articles
-
Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy.Nucleic Acids Res. 2001 Feb 1;29(3):841-9. doi: 10.1093/nar/29.3.841. Nucleic Acids Res. 2001. PMID: 11160908 Free PMC article.
-
Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.Mol Pharmacol. 2008 Dec;74(6):1587-98. doi: 10.1124/mol.108.048751. Epub 2008 Sep 22. Mol Pharmacol. 2008. PMID: 18809672
-
Neuroprotective effects of ONO-1924H, an inhibitor of poly ADP-ribose polymerase (PARP), on cytotoxicity of PC12 cells and ischemic cerebral damage.Life Sci. 2004 Nov 26;76(2):151-62. doi: 10.1016/j.lfs.2004.04.057. Life Sci. 2004. PMID: 15519361
-
[Neuronal death: potential role of the nuclear enzyme, poly (ADP-ribose) polymerase].Bull Acad Natl Med. 2001;185(3):555-63; discussion 564-5. Bull Acad Natl Med. 2001. PMID: 11501263 Review. French.
-
Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors.Pharmacol Res. 2002 Feb;45(2):73-85. doi: 10.1006/phrs.2001.0935. Pharmacol Res. 2002. PMID: 11846617 Review.
Cited by
-
Biological function, mediate cell death pathway and their potential regulated mechanisms for post-mortem muscle tenderization of PARP1: A review.Front Nutr. 2022 Dec 15;9:1093939. doi: 10.3389/fnut.2022.1093939. eCollection 2022. Front Nutr. 2022. PMID: 36590225 Free PMC article. Review.
-
Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa.Biochem J. 2005 Feb 1;385(Pt 3):667-75. doi: 10.1042/BJ20041480. Biochem J. 2005. PMID: 15458385 Free PMC article.
-
Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy.Nucleic Acids Res. 2001 Feb 1;29(3):841-9. doi: 10.1093/nar/29.3.841. Nucleic Acids Res. 2001. PMID: 11160908 Free PMC article.
-
Structural Implications for Selective Targeting of PARPs.Front Oncol. 2013 Dec 20;3:301. doi: 10.3389/fonc.2013.00301. Front Oncol. 2013. PMID: 24392349 Free PMC article. Review.
-
Poly(ADP-ribose) polymerase inhibition: past, present and future.Nat Rev Drug Discov. 2020 Oct;19(10):711-736. doi: 10.1038/s41573-020-0076-6. Epub 2020 Sep 3. Nat Rev Drug Discov. 2020. PMID: 32884152 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
